Product Information
DOFETILIDE 250 MCG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $0.1925 per EA under NDC 69452013217. Its NADAC has been published 428 times since Jun 13, 2018.
FDA first approved this application on Apr 10, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
Bionpharma Inc.NDC
69452013217
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOFETILIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208625FDA Approved
4/10/2018
TE Code
AB
On Market Since
4/11/2018
Pharmacological Classes
Price Statistics
The NADAC for DOFETILIDE 250 MCG CAPSULE has been published 428 times since Jun 13, 2018, and over the history we have for it it has declined 95.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1925 per EA |
|---|---|
| All-time high | $4.9785 (Sep 12, 2018) |
| All-time low | $0.1886 (Feb 18, 2026) |
| 52-week high | $0.2178 |
| 52-week low | $0.1886 |
| Median price | $0.8056 |
| Average price | $1.2717 |
| Largest weekly change | +51.6% (Aug 17, 2022) |
| Weeks tracked | 428 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOFETILIDE 250 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 250 MCG CAPSULE, manufactured by Bionpharma Inc., is $0.1925 per EA (NDC 69452013217), effective Aug 19, 2026.
How has the price of DOFETILIDE 250 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOFETILIDE 250 MCG CAPSULE has declined 95.6%. It has been tracked across 428 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for DOFETILIDE 250 MCG CAPSULE?
Since Jun 13, 2018, the NADAC for DOFETILIDE 250 MCG CAPSULE has ranged from a low of $0.1886 (Feb 18, 2026) to a high of $4.9785 (Sep 12, 2018), with a median of $0.8056 per EA.
Are there cheaper alternatives to DOFETILIDE 250 MCG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOFETILIDE 250 MCG CAPSULE, is $0.1886 per EA — about 2% below DOFETILIDE 250 MCG CAPSULE.
Who manufactures DOFETILIDE 250 MCG CAPSULE?
DOFETILIDE 250 MCG CAPSULE (NDC 69452013217) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.